Further investigation into methylation patterns at specific CpG sites within the EZH2 promoter, cg08558971 and cg18416251, revealed distinct and inverse methylation profiles at different tumor stages, each significantly linked to overall survival. This evidence concerns the gene EZH2 and neoplasm.